@entity1701 plus XXXX : a higher risk factor for @entity64 ?

@entity1 @entity4789 @entity2208 @entity64 @entity407 @entity101 @entity882 @entity6 @entity1701 @entity1151 @entity4555 @entity1031 @entity12009 @entity166 @entity715 @entity4297 @entity884
To compare clinical and laboratory findings between @entity1 with @entity1701 ( @entity1701 ) versus secondary @entity12009 due to @entity4789 ( @entity12009 ) (according to Jones criteria). Seventy-three @entity12009 @entity1 (Sapporo criteria) were enrolled, and demographic, clinical, and laboratory data were collected. Exclusion criteria were @entity4297 and previous @entity166 . @entity1 were divided into two groups: @entity1701 (n  =  68) and @entity12009 (n  =  5). The mean current age, disease duration, frequencies of female gender, and Caucasian race were similar in @entity12009 and @entity1701 @entity1 (P  >  0.05). Remarkably, the frequency of @entity64 was significantly higher in @entity12009 compared to @entity1701 @entity1 (80% vs. 25%, P  =  0.02). Of note, echocardiogram of these @entity1 did not show @entity715 . No significant differences were found in peripheral @entity1031 events (P  =  1.0), @entity1151 (P  =  1.0), @entity2208 (P  =  0.16), @entity882 (P  =  0.36), arterial events (P  =  0.58), and @entity715 of small vessels (P  =  1.0). There were no differences in the frequencies of comorbidities such as @entity6 , @entity101 , smoking, and @entity407 in both groups (P  >  0.05). The frequencies of @entity4555 , IgG, and IgM anticardiolipin were similar in two groups. @entity12009 @entity1 associated with @entity4789 without @entity884 may imply a high @entity64 risk as compared with @entity1701 , and future studies are needed to confirm this finding.
